法规动态

FDA、EMA、TGA 及全球法规动态

#2861 ×

2026年9月3日•1 分钟阅读

FDA Approves Apotex CILOSTAZOL (ANDA077030)

FDA has approved Apotex's oral cilostazol tablets (50 mg and 100 mg) under ANDA 077030, adding a generic phosphodiesterase‑3 inhibitor to the market.